Conclusions
Selection of the appropriate treatment path for the patient with CAP is a complex issue. Important factors that can guide the decision-making process are beginning to be understood. Nevertheless, in vitro evidence of the ability of an antibiotic to kill a bacterium is still the main determinant of antibiotic choice. More research is necessary, especially in the area of clinical comparisons of antibiotic efficacy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albaum, M. N., Hill, L. C., Murphy, M., Li, Y.-H., Fuhrman, C. R., Britton, C. A., Kapoor, W. N., Fine, M. J., & PORT Investigators. (1996). Interobserver reliability of the chest radiograph in community-acquired pneumonia. Chest, 110, 343–350.
American Thoracic Society. (1993). Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am. Rev. Respir. Dis., 148, 1418–1426.
Ausina, V., Coll, P., Sambeat, M., Puig, I., Condom, M.J., Luquin, M., Ballester, F., & Prats, G. (1988). Prospective study on the etiology of community-acquired pneumonia in children and adults in Spain. Eur. J. Clin. Microbiol. Infect. Dis., 7, 343–347.
Baldwin, D. R., Honeybourne, D., & Wise, R. (1992a). Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob. Agents Chemother., 36, 1171–1175.
Baldwin, D. R., Honeybourne, D., & Wise, R. (1992b). Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance. Antimicrob. Agents Chemother., 36, 1176–1180.
Bartlett, J. G., Breiman, R. F., Mandell, L. A., & File, T. M. (1998). Community-acquired pneumonia in adults: guidelines for management, Clin. Infect. Dis., 26, 811–838.
Berntsson, E., Blomberg, J., Lagergard, T., & Trollfors, B. (1985). Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur. J. Clin. Microbiol., 4, 268–272.
British Thoracic Society. (1987). Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcome. Quart. J. Med., 62, 195–220.
British Thoracic Society. (1993). Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br. J. Hosp. Med., 49, 46–350.
British Thoracic Society Research Committee and the Public Health Laboratory Service. (1992). The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit. Respir. Med., 86, 7–13.
Bushyhead, J. B., Wood, R. W., Tompkins, R. K., Wolcott, B. W., & Diehr, P. (1983). The effect of chest radiographs on the management and clinical course of patients with acute cough. Medical Care, 21, 661–673.
Chan, R., Hemeryck, L., O’Regan, M., Clancy, L., & Feely, J. (1995). Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial. Br. Med. J., 310, 1360–1362.
Coley, C. M., Li, Y.-H., Medsger, A. R., Marrie, T. J., Fine, M. J., Kapoor, W. N., Lave, J. R., Detsky, A. S., Weinstein, M. C., & Singer, D. E. (1996). Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia. Arch. Intern. Med., 156, 1565–1571.
Diehr, P., Wood, R. W., Bushyhead, J. B., Krueger, L., Wolcott, B. W., & Tompkins, R. K. (1984). Prediction of pneumonia in outpatients with acute cough—a statistical approach. J. Chron. Dis., 37, 215–225.
Dorca, J., Bello, S., Blanquer, J., de Celis, R., Molinos, L., Torres, A., Verano, A., & Zalacain, R. (1997). Diagnostico y tratamiento de la neumonia adquirida en la comunidad. Arch. Bronconeumol., 33, 240–246.
Drusano, G. L., & Craig, W. A. (1997). Relevance of pharmaco-kinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections, J. Chemother., 9, 38–44.
Durocher, A., Saulnier, F., Beuscart, R., Dievart, F., Bart, F., Deturck, R., & Wattel, F. (1988). A comparison of three severity score indexes in an evaluation of serious bacterial pneumonia. Intensive Care Med., 14, 39–43.
European Study on Community-Acquired Pneumonia Committee. (1998). Guidelines for management of adult community-acquired lower respiratory tract infections. Eur. Respir. J., 11, 986–991.
Everett, M. T. (1983). Major chest infection managed at home. Practitioner, 227, 1743–1754.
Ewig, S., Ruiz, M., Mensa, J., Marcos, M. A., Martinez, J. A., Arancibia, F., Niederman, M. S., & Torres, A. (1998). Severe community acquired pneumonia. Assessment of severily criteria. Am, J. Respir. Crit. Care Med., 158, 1102–1108.
Fang, G.-D., Fine, M., Orloff, J., Arisumi, D., Yu, V. L., Kapoor, W., Grayston, J. T., Wang, S. P., Kohler, R., Muder, R. R., Yee, Y. C., Rihs, J. D., & Vickers, R. M. (1990). New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine, 69, 307–316.
Farr, B. M., Sloman, A. J., & Fisch, M. J. (1991). Predicting death in patients hospitalized for community-acquired pneumonia. Ann. Intern. Med., 115, 428–436.
Feldman, C., Kallenbach, J. M., Levy, H., Reinach, S. G., Hurwitz, M. D., Thorburn, J. R., & Koornhof, H. J. (1989). Community-acquired pneumonia of diverse aetiology: prognostic features in patients admitted to an intensive care unit and a “severity of illness” score. Intensive Care Med., 15, 302–307.
Feldman, C., Ross, S., Goolam Mahomed, A., Omar, J., & Smith, C. (1995). The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respir. Med., 89, 187–192.
Fine, M. J., Smith, D. N., & Singer, D. E. (1990). Hospitalization decision in patients with community-acquired pneumonia: a prospective cohort study. Am. J. Med., 89, 713–721.
Fine, M. J., Hanusa, B. H., Lave, J. R., Singer, D. E., Stone, R. A., Weissfeld, L. A., Coley, C. M., Marrie, T. J., & Kapoor, W. N. (1995). Comparison of a disease-specific and a generic severity of illness measure Cor patients with community-acquired pneumonia. J. Gen. Intern. Med., 10, 359–368.
Fine, M. J., Smith, M. A., Carson, C. A., Mutha, S. S., Sankey, S. S., Weissfeld, L. A., & Kapoor, W. N. (1996). Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA, 274, 134–141.
Fine, M. J., Auble, T. E., Yealy, D. M., Hanusa, B. H., Weissfeld, L. A., Singer, D. E., Coley, C. M., Marrie, T. J., & Kapoor, W. N. (1997). A prediction rule to identify low-risk patients with community-acquired pneumonia. N. Engl. J. Med., 336, 243–250.
Fine, M. J., Hough, L. J., Medsger, A. R., Li, Y.-H., Ricci, E. M., Singer, D. E., Marrie, T. J., Coley, C. M., Walsh, M. B., Karpf, M., Lahive, K. C., & Kapoor, W. N. (1997). The hospital admission decision for patients with community-acquired pneumonia. Arch. Int. Med., 157, 36–44.
Fredlund, H., Bodin, L., Back, E., Holmberg, H., Krook, A., & Rydman, H. (1987). Antibiotic therapy in pneumonia: a comparative study of parenteral and oral administration of penicillin. Scand. J. Infect. Dis., 19, 459–466.
Gialdroni Grassi, G. & Bianchi, L. (1995). Guidelines for the management of community-acquired pneumonia in adults. Monaldi Arch. Chest Dis., 50. 21–27.
Gilbert, K., Gleason, P. P., Singer, D. E., Marrie, T. J., Coley, C. M., Obrosky, D. S., Lave, J. R., Kapoor, W. N., & Fine, M. J. (1998). Variations in antimicrobial use and cost in more than 2000 patients with community-acquired pneumonia. Am. J. Med., 104, 17–27.
Gleason, P. P., Kapoor, W. N.. Stone, R. A., Lave, J. R., Obrosky, D. S., Schulz, R., Singer, D. E., Coley, C. M., Marrie, T. J., & Fine, M. J. (1997). Medical outcomes and antimicrobial costs with the use of the American Thoracic Society Guidelines for outpatients with community-acquired pneumonia. JAMA, 278, 32–39.
Goldstein, F. W., & Acar. J. F. (1996). Antimicrobial resistance among lower respiratory tract isolates of Streptococcus pneumoniae: results of a 1992–93 western Europe and U.S.A. collaborative surveillance study. The Alexander Project Collaborative Group. J. Antimicrob. Chemother, 38 (Suppl. A), 71–84.
Gomez, J., Banos, V., Ruiz Gomez, J., Soto, M. C., Munoz, L., Nunez, M. L. C. M., & Valdes, M. (1996). Prospective study of epidemiology and prognostic factors in community-acquired pneumonia. Eur. J. Clin. Microbiol. Infect. Dis., 15, 556–560.
Grasela, T. H., Welage, L. S., Walawander, C. A., Timm, E. G., Pelter, M. A., Poirier, T. I., & Walters, J. K. (1990). A nationwide survey of antibiotic prescribing patterns and clinical outcomes in patients with bacterial pneumonia. Pharmacoepidemiology, 24, 1220–1225.
Hand, W. L., & King-Thompson, N. L. (1986). Contrasts between antibiotic uptake and subsequent intracellular bactericidal activity. Antimicrob. Agents Chemother., 29, 135–140.
Heckerling, P. S. (1986). The need for chest roentgenograms in adults with acute respiratory illness. Clinical predictors. Arch. Intern. Med., 146, 1321–1324.
Heffron, R. (1939). Pneumonia, with special reference to pneumococcus lobar pneumonia. Cambridge, MA: Harvard University Press.
Hirani, N. A., & Macfarlane, J. T. (1997). Impact of management guidelines on the outcome of severe community acquired pneumonia. Thorax, 52, 17–21.
Houston, M. S., Silverstein, M. D., & Suman, V. J. (1995). Community-acquired lower respiratory tract infection in the elderly: a community-based study of incidence and outcome. J. Am. Board Fam. Pract., 8, 347–356.
Huchon, G. J., Gialdroni Grassi, G., Leophonte, P., Manresa, F., Schaberg, T., & Woodhead, M. (1996). Initial antibiotic-therapy for lower respiratory tract infection in the community: a European survey. Eur. Respir. J., 9, 1590–1595.
Kurashi, N. Y., al-Hamdan, A., Ibrahim, E. M., al-Idrissi, H. Y., & al-Bayari, T. H. (1992). Community acquired acute bacterial and atypical pneumonia in Saudi Arabia. Thorax, 47, 115–118.
Laing, R. B. S., Mackenzie, A. R., Shaw, H., Gould, I. M., & Douglas, J. G. (1998). The effect of intravenous-to-oral switch guidelines on the use of parenteral antimicrobials in medical wards. J. Antimicrob. Chemother., 42, 107–111.
Leroy, O., Santre, C., Beuscart, C., Georges, H., Guery, B., Jacquier, J. M., & Beaucaire, G. (1995). A five year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Cure Med., 21, 24–31.
Macfarlane, J. T., Finch, R. G., Ward, M. J., & Macrae, A. D. (1982). Hospital study of adult community-acquired pneumonia. Lancet, 2, 255–258.
Mandell, L. A., Niederman, M., & the Canadian Community Acquired Pneumonia Consensus Conference Group. (1993). Antimicrobial treatment of community-acquired pneumonia in adults: a conference report. Can. J. Infect. Dis., 4.25–28.
Marrie, T. J., Haldane, E. V., Faulkner, R. S., Durant, H., & Kwan, C. (1985). Community-acquired pneumonia requiring hospitalization. Is it different in the elderly? J. Am. Geriatr. Soc., 33, 671–680.
Meehan, T. P., Fine, M. J., Krumholz, H. M., Scinto, J. D., Galusha, D. H., Mockalis, J. T., Weber, G. F., Petrillo, M. K., Houck, P. M., & Fine, J. M. (1997). Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA, 278, 2080–2084.
Melbye, H., & Dale, K. (1992). Interobserver variability in the radiographic diagnosis of adult outpatient pneumonia. Acta Radiologica, 33, 79–81.
Melbye, H., Berdal, B. P., Straume, B., Russell, H., Vorland, L., & Thacker, W. L. (1992a). Pneumonia-a clinical or radiographic diagnosis? Scand. J. Infect. Dis., 24, 647–655.
Melbye, H., Straume, B., Aasebo, U., & Dale, K. (1992b). Diagnosis of pneumonia in adults in general practice. Scand. J. Prim. Health Care, 10, 226–233.
Metlay, J. P., Schulz, R., Li, Y.-H., Singer, D. E., Marrie, T. J., Coley, C. M., Hough, L. J., Obrosky, D. S., Kapoor, W. N., & Fine, M. J. (1997a). Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch. Int. Med., 157, 1453–1459.
Metlay, J. P., Kapoor, W. N., & Fine, M. J. (1997b). Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA, 278, 1440–1445.
Moine, P., Vercken, J.-P., Chevret, S., Chastang, C., Gajdos, P., & French Study Group for Community-Acquired Pneumonia in the Intensive Care Unit. (1994). Severe community-acquired pneumonia. Etiology, epidemiology and prognosis factors. Chest, 105, 1487–1495.
Mundy, L. M., Auwaerter, P. G., Oldach, D., Warner, M. L., Burton, A., Vance, E., Gaydos, C. A., Joseph, J. M., Gopalan, R., Moore, R. D., Quinn, T. C., Charache, P., & Bartlett, J. G. (1995). Community-acquired pneumonia: impact of immune status. Am. J. Respir. Crit. Care Med., 152, 1309–1315.
Mundy, L. M., Oldach, D., Auwaerter, P. G., Gaydos, C. A., Moore, R. D., Bartlett, J. G., Quinn, T. C., & Hopkins CAP Team. (1998). Implications for macrolide treatment in community-acquired pneumonia. Chest. 113, 1201–1206.
Neill, A. M., Martin, I. R., Weir, R., Anderson, R., Chereshsky, A., Epton, M. J., Jackson, R., Schousboe, M., Frampton, C., Hutton, S., Chambers, S. T., & Town, G. I. (1996). Community-acquired pneumonia: aetiology and usefulness of severity criteria on admission. Thorax, 51, 1010–1016.
Olaechea, P. M., Quintana, J. M., Gallardo, M. S., Insausti, J., Maravi, E., & Alvarez, B. (1996). A predictive model for the treatment approach to community-acquired pneumonia in patients needing ICU admission. Int. Care Med., 22, 1294–1300.
Omidvari, K., de Boisblanc, B. P., Karam, G., Nelson, S., Haponik, E., & Summer, W. (1998). Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis. Respir. Med., 92, 1032–1039.
Örtqvist, A. (1995). Antibiotic treatment of community-acquired pneumonia in clinical practice: a European perspective. J. Antimicrob. Chemother, 35, 205–212.
Örtqvist, A., Sterner, G., & Nilsson, J. A. (1985). Severe community-acquired pneumonia, factors influencing need of intensive care treatment and prognosis. Scand. J. Infect. Dis., 17, 377–386.
Örtqvist, A., Hedlund, J., Grillner, L., Jalonen, E., Kallings, I., Leinonen, M., & Kalin, M. (1990). Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur. Respir. J., 3, 1105–1113.
Pachon, J., Prados, M. D., Capote, F., Cuello, J. A., Garnacho, J., & Verano, A. (1990). Severe community-acquired pneumonia. Etiology, prognosis and treatment. Am. Rev. Respir. Dis., 142, 369–373.
Porath, A., Schlaeffer, F., & Lieberman, D. (1996). Appropriateness of hospitalization of patients with community-acquired pneumonia. Ann. Intern. Med., 27, 176–183.
Ramirez, J. A., Srinath, L., Ahkee, S., Huang, A., & Raff, M. J. (1995). Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia. Arch. Intern. Med., 155, 1273–1276.
Rello, J., Quintana, E., Ausina, V., Net, A., & Prats, G. (1993). A three year study of severe community-acquired pneumonia with emphasis on outcome. Chest, 103, 232–235.
Rosenthal, G. E., Harper, D. L., Shah, A., & Covinsky, K. E. (1997). A regional evaluation of variation in low-severity hospital admissions. J. Gen. Intern. Med., 12, 416–422.
Schoenwald, S., Skerk, V., Petricevic, I., Car, V., Majerus-Misic, L., & Gunjaca, M. (1991). Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia. Eur. J. Clin. Microbiol. Infect. Dis., 10, 877–880.
Siegel, R. E., Halpern, N. A., Almenoff, P. L., Lee, A., Cashin, R., & Greene, J. G. (1996). A prospective randomized study of inpatient IV antibiotics for community-acquired pneumonia. The optimal duration of therapy. Chest, 110, 965–971.
Societe de Pathologie Infectieuse de Langue Francaise. (1991). Les infections des voies respiratoires. Med. Mal. Infect., 21, 1–8.
Steinhoff, D., Lode, H., Ruckdeschel, G., Heidrich, B., Rolfs, A., Fehrenbach, F.J., Mauch, H., Hoffken, G., & Wagner, J. (1996). Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalised patients in Berlin, Clin. Infect. Dis., 22, 958–964.
Tang, C. M., & Macfarlane, J. T. (1993). Early management of younger adults dying of community-acquired pneumonia. Respir. Med., 87, 289–294.
Torres, A., Serra-batlles, J., Ferrer, A., Jimenez, P., Celis, R., Cobo, E., & Rodriguez-Roisin, R. (1991). Severe community-acquired pneumonia. Epidemiology and prognostic factors. Am. Rev. Respir. Dis., 144, 312–318.
van Eeden, S. F., Coetzee, A. R., & Joubert, J. R. (1988). Community-acquired pneumonia-factors influencing intensive care admission. South Afr. Med. J., 73, 77–81.
Venkatesan, P., Gladman, J., Macfarlane, J. T., Barer, D., Berman, P., Kinnear, W., & Finch, R. G. (1990). A hospital study of community-acquired pneumonia in the elderly. Thorax, 45, 254–258.
Weingarten, S. R., Riedinger, M. S., Varis, G., Noah, M. S., Belman, M. J., Meyer, R. D., & Ellrodt, A. G. (1994). Identification of low-risk hospitalized patients with pneumonia. Implications for early conversion to oral antimicrobial therapy. Chest, 105, 1109–1115.
Weingarten, S. R., Riedinger, M. S., Hobson, P., Noah, M. S., Johnson, B., Giugliano, G., Norian, J., Belman, M. J., & Ellrodt, A. G. (1996). Evaluation of a pneumonia practice guideline in an intervention trial. Am. J. Respir. Cril. Care Med., 153, 1110–1115.
Woodhead, M. A. (1988). Studies on pneumonia in the community and in hospital in Nottingham. Dissertation, University of Nottingham.
Woodhead, M. A. (1992). Management of pneumonia. Respir. Med., 86, 459–469.
Woodhead, M. (1998). Management of pneumonia in the outpatient setting. Semin. Respir. Infect., 13, 8–16.
Woodhead, M. A., & Macfarlane, J. T. (1987). Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias. Br. J. Dis. Chest, 81, 133–139.
Woodhead, M., Macfarlane, J., Rodgers, F. G., Laverick, A., Pilkington, R., & Macrae A. D. (1985). Aetiology and outcome of severe community-acquired pneumonia. J. Infect., 10, 204–210.
Woodhead, M. A.. Macfarlane, J. T., McCracken, J. S., Rose, D. H., & Finch, R. G. (1987). Prospective study of the aetiology and outcome of pneumonia in the community. Lancet, 1, 671–674.
Woodhead, M. A., Arrowsmith, J. E., Chamberlain-Webber, R., Wooding, S., & Williams, I. (1991). The value of routine microbial investigation in community-acquired pneumonia. Respir. Med., 85, 313–317.
Young, M., & Marrie, T. J. (1994). Interobserver variability in the interpretation of chest roentgenograms of patients with possible pneumonia. Arch. Intern. Med., 154, 2729–2732.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Woodhead, M. (2002). Treatment of Community-Acquired Pneumonia. In: Marrie, T.J. (eds) Community-Acquired Pneumonia. Springer, Boston, MA. https://doi.org/10.1007/0-306-46834-4_10
Download citation
DOI: https://doi.org/10.1007/0-306-46834-4_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46432-4
Online ISBN: 978-0-306-46834-6
eBook Packages: Springer Book Archive